Transmissibility of SARS-CoV-2 among fully vaccinated individuals
MJ Knol, JA Backer, HE de Melker… - The Lancet Infectious …, 2022 - thelancet.com
Vaccine effectiveness studies have conclusively demonstrated the benefit of COVID-19
vaccines in reducing individual symptomatic and severe disease, resulting in reduced …
vaccines in reducing individual symptomatic and severe disease, resulting in reduced …
[HTML][HTML] Booster shots for COVID-19—the debate continues
T Burki - The Lancet Infectious Diseases, 2021 - thelancet.com
On Sept 1, 2021, the European Centre for Disease Prevention and Control (ECDC) issued a
technical report outlining the public health case for booster doses of the COVID-19 vaccines …
technical report outlining the public health case for booster doses of the COVID-19 vaccines …
Risking further COVID-19 waves despite vaccination
S Contreras, V Priesemann - The Lancet Infectious Diseases, 2021 - thelancet.com
The sudden outbreak and global spread of COVID-19 took the world by surprise. Policy
makers started to work side-by-side with theoreticians, as there were and still are many …
makers started to work side-by-side with theoreticians, as there were and still are many …
[HTML][HTML] Responsive and agile vaccination strategies against COVID-19 in India
S Mandal, N Arinaminpathy, B Bhargava… - The Lancet Global …, 2021 - thelancet.com
As of June, 2021, India is facing an overwhelming second wave of COVID-19. In the worst
affected states, including Maharashtra and Uttar Pradesh, healthcare resources are …
affected states, including Maharashtra and Uttar Pradesh, healthcare resources are …
[HTML][HTML] Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Background The first COVID-19 vaccine outside a clinical trial setting was administered on
Dec 8, 2020. To ensure global vaccine equity, vaccine targets were set by the COVID-19 …
Dec 8, 2020. To ensure global vaccine equity, vaccine targets were set by the COVID-19 …
Hospitalisation among vaccine breakthrough COVID-19 infections
PV Juthani, A Gupta, KA Borges, CC Price… - The Lancet Infectious …, 2021 - thelancet.com
Emergency use authorisations granted by the US Food and Drug Administration for three
SARS-CoV-2 vaccines represent an important milestone in the response to the COVID-19 …
SARS-CoV-2 vaccines represent an important milestone in the response to the COVID-19 …
Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
Many high-income countries have rapidly pivoted from hard decisions about who may
receive COVID-19 vaccines, due to shortages, to equally hard decisions about who must …
receive COVID-19 vaccines, due to shortages, to equally hard decisions about who must …
Five priorities for universal COVID-19 vaccination
A Abecassis - The Lancet, 2021 - thelancet.com
Comment 286 www. thelancet. com Vol 398 July 24, 2021 and enable the rapid
manufacturing of products through technology transfers should be supported, particularly in …
manufacturing of products through technology transfers should be supported, particularly in …
[HTML][HTML] Equitable distribution of COVID-19 vaccines
T Burki - The Lancet. Infectious Diseases, 2021 - ncbi.nlm.nih.gov
If everything goes according to plan, November 2020 will be remembered as the beginning
of the end of the COVID-19 pandemic. The past few weeks have seen a remarkable run of …
of the end of the COVID-19 pandemic. The past few weeks have seen a remarkable run of …
[HTML][HTML] A promising inactivated whole-virion SARS-CoV-2 vaccine
I Isakova-Sivak, L Rudenko - The Lancet Infectious Diseases, 2021 - thelancet.com
The ongoing COVID-19 pandemic is the only outbreak to date in which the time from
identification of a pathogen to the presentation of the first clinical trial results for a specific …
identification of a pathogen to the presentation of the first clinical trial results for a specific …